JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Reply To Clarification Sought By National Stock Exchange Of India Ltd. On Price Movement.
Reply To Clarification Sought By National Stock Exchange Of India Ltd. On Price Movement.19-11-2020
19-11-2020
JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Clarification sought from Jagsonpal Pharmaceuticals Ltd
The Exchange has sought clarification from Jagsonpal Pharmaceuticals Ltd on November 19, 2020, with reference to Movement in Price.The reply is awaited.19-11-2020
JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Results For The Quarter And Half Year Ended 30.09.2020
SUBMISSION OF UN-AUDITED FINANCIAL RESULTS ALONG WITH LIMITED REVIEW REPORT FOR THE QUARTER AND HALF YEAR ENDED 30TH SEPTEMBER, 2020.10-11-2020
JAGSONPAL PHARMACEUTICALS LTD. - 507789 - OUTCOME OF THE MEETING OF BOARD OF DIRECTORS OF JAGSONPAL PHARMACEUTICALS LIMITED HELD ON NOVEMBER 10TH, 2020
We wish to inform you that the Board of Directors of the Company at their meeting held today, (i.e. Tuesday, the 10th Day of November, 2020), have inter alia, approved and taken on record the followings: 1. Un-Audited Financial Results of the Company for the Quarter and Half Year ended 30th September, 2020; 2. Limited Review Report for the Quarter and Half Year ended 30th September, 2020; 3. And Other Agenda items. Further, the meeting was commenced at 12:00 Noon and concluded at 1:30 P.M.10-11-2020
JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Board Meeting Intimation for Un-Audited Financial Results For The Quarter And Half Year Ended September 30, 2020
JAGSONPAL PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/11/2020 ,inter alia, to consider and approve the Un-Audited Financial Results of the company for the quarter and half year ended 30th September, 2020 and other agenda items with the permission of the chair.02-11-2020
JAGSONPAL PHARMACEUTICALS LTD. - 507789 - SUBMISSION OF CERTIFICATE UNDER SUB - REGULATION 9 & 10 REGULATION 40 OF THE SEBI (LISTING OBLIGATIONS & DISCLOSURE REQUIREMENT) REGULATIONS, 2015 FOR THE HALF YEAR ENDED ON 30Th SEPTEMBER, 2020.
SUBMISSION OF CERTIFICATE UNDER SUB - REGULATION 9 & 10 REGULATION 40 OF THE SEBI (LISTING OBLIGATIONS & DISCLOSURE REQUIREMENT) REGULATIONS, 2015 FOR THE HALF YEAR ENDED ON 30th SEPTEMBER, 2020.28-10-2020
Jagsonpal Pharmaceuticals Ltd - 507789 - Shareholding for the Period Ended September 30, 2020
Jagsonpal Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2020. For more details, kindly Click here20-10-2020
JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Compliance Certificate (Pursuant To Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulation, 2015 For The Half Year Ended 30Th September, 2020.
Compliance Certificate (Pursuant to Regulation 7(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015 for the Half Year ended 30th September, 2020.20-10-2020
JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74 (5) of the SEBI (Depositories and Participants) Regulations, 2018 for the Quarter ended 30 September, 2020.20-10-2020
JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Statement Of Investor Complaints For The Quarter Ended September 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- NANDITA SINGHDesignation :- Company Secretary and Compliance Officer16-10-2020